Fourth Quarter Conference Calls, In Brief
Executive Summary
Lipitor in perspective: With $6.45 bil. in annual sales in 2001, Pfizer's Lipitor generates more revenues than the annual Gross Domestic Product of 78 countries, based on calculations of purchasing power parity by the Central Intelligence Agency. If Lipitor meets growth expectations in 2002, it should surpass the GDP of Tajikistan ($7.3 bil.)....Zocor heart protection study: Merck will present data on the effect of Zocor (simvastatin) in the 20,000-patient Heart Protection Study at the American College of Cardiology meeting in March. Preliminary results show that Zocor "reduced the risk of heart attacks and stroke by at least one-third," company says. A filing based on the data is planned for this year...
You may also be interested in...
Prempro Cancer Risk Addressed In 550,000 Physician Letters, Label Review
Wyeth is sending letters to approximately 550,000 physicians as part of a Prempro risk management program to address risks associated with use of the hormone combination for cardiovascular disease and osteoporosis prevention
Prempro Cancer Risk Addressed In 550,000 Physician Letters, Label Review
Wyeth is sending letters to approximately 550,000 physicians as part of a Prempro risk management program to address risks associated with use of the hormone combination for cardiovascular disease and osteoporosis prevention
Barr Generic Premarin Development Plan Includes Exclusive Supply Deal
Barr anticipates that its exclusive supply agreement with Natural Biologics will permit pricing of its Premarin generic as a single-source generic